Back to Rankings

BTMD

bioteD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
BTMD vs peer average
50/100
BTMD vs. peer average (D vs. D)
Grade spread
B 2 · D 5 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

MNOV is the first available peer comparator.

Included only as a same-sector, similar-market-cap reference from the packet. It is not a direct operating comparator for BTMD's hormone-optimization, practitioner-network model, so it should not drive valuation.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerMNOVMediciNova
BTMD
biote
MNOV
MediciNova
Grade
D
B
Momentum
31
85
Value
72
41
Sentiment
24
47
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs MNOV

BTMD / MNOV
Grade Position
In line
BTMD vs. peer average (D vs. D)
50/100
Momentum
31
MNOV
Value
72
BTMD
Sentiment
24
MNOV

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs BTMD
1
MNOV
MNOV
B
80/100
-2
2
SERA
SERA
F
20/100
+1
3
ACTU
ACTU
F
20/100
+1
4
RANI
Rani Therapeutics Holdings Inc Class A Common
B
80/100
-2
5
VRCA
Verrica Pharmaceuticals Inc Common
D
40/100
Even
MNOV is the first peer returned for this comparison set.